Millipore Sigma Vibrant Logo

676490 VEGFR2D1-7, Human, Recombinant, S. frugiperda

SDB (Sicherheitsdatenblätter), Analysenzertifikate und Qualitätszertifikate, Dossiers, Broschüren und andere verfügbare Dokumente.

Synonyme: Vascular Endothelial Growth Factor Receptor 2D1-7, Soluble KDR/Flk-1

View Products on Sigmaaldrich.com
676490
Preis & Verfügbarkeit

Übersicht

Replacement Information

Preis & Verfügbarkeit

Bestellnummer VerfügbarkeitVerpackung St./Pkg. Preis Menge
676490-50UG
Verfügbarkeit wird abgerufen...
—
Eingeschränkte Verfügbarkeit Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

      		 Kst.-Ampulle 50 μg
      Preis wird abgerufen...
      Preis nicht abrufbar
      Die Mindestmenge muss ein Vielfaches sein von
      Maximum Quantity is
      Bei Bestätigung Weitere Informationen
      Sie haben () gespart
       
      —
      Bitte erfragen
      		 —
      Description
      OverviewRecombinant, human VEGFR-2 consisting of all 7 immunoglobulin-like extracellular domains, but lacking the single transmembrane region and the intracellular split tyrosine kinase domain expressed in S. frugiperda insect cells. Binding of ligand to the full-length VEGFR-2 results in a high signaling activity and mitogenic activity in endothelial cells.
      Catalogue Number676490
      Brand Family Calbiochem®
      SynonymsVascular Endothelial Growth Factor Receptor 2D1-7, Soluble KDR/Flk-1
      References
      ReferencesRobinson, C.J., and Stringer, S.E. 2001 J. Cell Sci. 114, 853.
      Roeckl, W., et al. 1998. Exp. Cell Res. 241, 161.
      Product Information
      FormLyophilized
      FormulationLyophilized from 100 mM NaCl, 25 mM MES, pH 5.5.
      Quality LevelMQ100
      Applications
      Biological Information
      Biological activityMeasured by the ability to inhibit VEGF165-induced proliferation in human umbilical vein endothelial (HUVE) cells
      Purity≥90% by SDS-PAGE
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Blue Ice Only
      Toxicity Standard Handling
      Storage ≤ -70°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-70°C). Stock solutions are stable for up to 6 months at -70°C. Avoid freeze/thaw cycles of solutions.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      676490-50UG 04055977183665

      Documentation

      VEGFR2D1-7, Human, Recombinant, S. frugiperda SDB

      Titel

      Sicherheitsdatenblatt (SDB) 

      VEGFR2D1-7, Human, Recombinant, S. frugiperda Analysenzertifikate

      TitelChargennummer
      676490

      Literatur

      Übersicht
      Robinson, C.J., and Stringer, S.E. 2001 J. Cell Sci. 114, 853.
      Roeckl, W., et al. 1998. Exp. Cell Res. 241, 161.
      Datenblatt

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision16-September-2008 RFH
      SynonymsVascular Endothelial Growth Factor Receptor 2D1-7, Soluble KDR/Flk-1
      DescriptionRecombinant, human VEGFR-2 consisting of all 7 immunoglobulin-like extracellular domains, but lacking the single transmembrane region and the intracellular split tyrosine kinase domain expressed in S. frugiperda insect cells. Contains all of the domains necessary for high affinity binding to VEGF. VEGFR-2 has a lower affinity for VEGF165 than VEGFR-1. However, VEGFR-2 has a higher signaling activity and is reported to mediate almost all observed endothelial cell responses to VEGF, including the increased microvascular permeability and endothelial cell proliferation. VEGFR-2 requires heparin for binding VEGF165.
      FormLyophilized
      FormulationLyophilized from 100 mM NaCl, 25 mM MES, pH 5.5.
      Purity≥90% by SDS-PAGE
      Biological activityMeasured by the ability to inhibit VEGF165-induced proliferation in human umbilical vein endothelial (HUVE) cells
      SolubilityAqueous buffers (≥100 µg/ml) or H₂O (≥100 µg/ml)
      Storage ≤ -70°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-70°C). Stock solutions are stable for up to 6 months at -70°C. Avoid freeze/thaw cycles of solutions.
      Toxicity Standard Handling
      ReferencesRobinson, C.J., and Stringer, S.E. 2001 J. Cell Sci. 114, 853.
      Roeckl, W., et al. 1998. Exp. Cell Res. 241, 161.